Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-01-18FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc., resulting in an approved labeling update for the…
-
FDA approval · 2019-01-02FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic pramipexole dihydrochloride under an Original Application (ANDA). The drug is indicat…
-
FDA approval · 2018-12-19FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approval of a generic pramipexole dihydrochloride product under an Original Application (ANDA) by Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2018-11-29FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc., resulting in updated labeling for the drug.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant [Phase 2]
Phase 2 clinical trial investigating suvorexant, a hypocretin antagonist, for restless legs syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms [Phase 3]
Phase 3 trial update evaluating oxycodone/naloxone prolonged release versus placebo for improving symptoms of moderate to severe restless le…
-
EMA withdrawal · 2018-07-11EMA Application withdrawn: Rotigotine Mylan (rotigotine) — Mylan S.A.S
The EMA has withdrawn the marketing authorization application for Rotigotine Mylan (rotigotine) submitted by Mylan S.A.S, for restless legs …
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Restless Legs Syndrome in Hemodialysis Patients [NA]
A clinical trial studying restless legs syndrome in patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome [Phase 4]
Phase 4 trial evaluating the effect of rotigotine transdermal patch on cardiovascular markers in idiopathic restless legs syndrome has been …
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
A completed observational clinical trial evaluating inflammatory bowel disease patients with restless legs syndrome and iron deficiency.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food [Phase 1]
Phase 1 study update evaluating how ropinirole is absorbed, distributed, metabolized and excreted, and how food affects its pharmacokinetics…
-
CLINICAL_TRIALS research · 2017-07-31Clinical Trial Update: New Data Analysis Methods for Actigraphy in Sleep Medicine
This clinical trial update describes new data analysis methods for actigraphy in sleep medicine and notes that the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.
A completed clinical trial investigating how periodic leg movements in restless legs syndrome relate to cardiovascular variability, heart ra…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Relationship Between Sensory and Motor Systems in Restless Leg Syndrome
A clinical trial investigating the relationship between sensory and motor systems in restless legs syndrome has completed. The study was spo…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
NINDS-sponsored trial evaluating ropinirole for restless legs syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Efficacy of Tyrosine in Restless Legs Syndrome [NA]
A completed clinical trial evaluated the efficacy of L-tyrosine for treating Restless legs syndrome.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Glutamate, Hyperarousal and Restless Legs Syndrome
A clinical trial update from Johns Hopkins University reports completion of a study examining glutamate, hyperarousal, and Restless Legs Syn…
-
FDA approval · 2017-02-28FDA Approved: ROPINIROLE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s generic ropinirole under an Original Application (ANDA 204022) for indications including Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) [Phase 2]
A Phase 2 safety and efficacy trial of IPX159 for Restless Legs Syndrome has completed. The study was sponsored by Impax Laboratories, LLC.
-
FDA approval · 2017-01-30FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA has approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc. No specific changes are detailed in the excer…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome [Phase 4]
Phase 4 clinical trial evaluating autonomic function and cardiovascular risk in restless legs syndrome has completed.
-
FDA approval · 2017-01-23FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves an original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome [Phase 4]
Phase 4 trial evaluating 12-week polysomnography of ropinirole controlled release for restless legs syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome [Phase 3]
Long-term safety data from a Phase 3 trial evaluating ropinirole XR in patients with Restless Legs Syndrome.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole [Phase 1]
A Phase 1 pharmacokinetic study examines how end-stage renal disease and hemodialysis influence ropinirole exposure in patients with restles…